12 providers, sorted by what a month-to-month buyer actually pays — cheapest first, no editorial ranking involved. 1 of 12 publish no price at all; those rows sink to the bottom rather than getting hidden.
Want our ranked take instead — pharmacy sourcing weighed against price? See Best Compounded Tirzepatide Providers. This page ranks nothing; it just sorts by cost.
FO
Found
Found's compounded-tirzepatide page carries the more direct of the two regulatory-category disclosures on this board — it states, in its own words, "Found partners exclusively with licensed 503A compounding pharmacies," and separately says those pharmacies operate "under Section 503A of the Federal Food, Drug, and Cosmetic Act," with medication "independently tested by a third-party laboratory before it reaches you.
$99/mo+
advertised
Medium confidence
What's advertised
Found's own homepage FAQ states, "compounded GLP-1s starting at $99/month (with flat pricing as your dose increases)." Its dedicated compounded-tirzepatide page repeats the flat-across-doses claim but renders the actual number only inside an interactive comparison graphic our text-only site check could not read.
What you actually pay
Found's own product page states pricing "reflects cash pay on a multi-month plan; see offer terms," and its FAQ adds, "Longer plans at 3, 6, and 12 months keep your monthly cost down" — meaning the advertised floor assumes prepaying for more than one month. The actual month-to-month (no-prepay) rate is not stated anywhere on the public pages we could read.
The catch
The $99/mo figure requires cash-paying for a multi-month plan up front, per Found's own product page — its FAQ confirms a shorter commitment costs more, but never states by how much.
CoreAge's tirzepatide page describes medication as "compounded in the USA" and prescriptions as overseen by "fully licensed and insured physicians," with every plan including "ongoing provider access," "24/7 Provider Support," and a patient community.
$149/mo+
advertised
High confidence
What's advertised
CoreAge's own product pages advertise sermorelin "starting at $99 per month" and tirzepatide "starting at $149 per month" — no dose-tier price list published for either.
What you actually pay
There is not a single flat $99 (or $149) plan that covers every dose: both figures are floors, not ceilings, and CoreAge does not publish what a higher dose actually costs — the real month-to-month number is something intake tells you, not the homepage.
yourEra runs its full product list — semaglutide, tirzepatide, NAD+, microdosing, and a not-yet-live "yourEra Optimum" tier — on one single-page site rather than separate product pages (a direct product-page URL we tried 404'd).
$169/mo+
advertised
High confidence
What's advertised
yourEra's homepage advertises "Tirzepatide: from $169/mo" — no dose-tier breakdown or ceiling published.
What you actually pay
There is no published number above the $169 floor: yourEra does not break pricing out by dose, so what a specific prescription costs is something you learn during signup, not from the homepage.
Henry Meds sells compounded tirzepatide as an oral, dissolving tablet.
$179/mo+
advertised
High confidence
What's advertised
Henry's own FAQ and treatment pages state plainly, "The price of GLP-1 medication varies by treatment plan and dosing, but starts at $179/month" — one monthly payment advertised to include "provider visit, medication and supplies, and ongoing care."
What you actually pay
There is no confirmed tirzepatide-specific number above that $179 floor: Henry's own pages state the $179 figure for its GLP-1 catalogue broadly (semaglutide, tirzepatide tablets, and more) rather than breaking tirzepatide out on its own, and no dose-tier price list is published anywhere we could find.
Other costs to budget for
Optional multi-month plans exist and may lower the effective monthly rate, but canceling one early for a non-medical reason means you "may be required to pay out the rest of your balance," per Henry's own FAQ.
Fridays' own /pricing page advertises "Starting at $198/mo" for compounded tirzepatide — a discounted price for its annual plan, valid only with promo code "NEWYOU12" ("SAVE 50%"). The same page shows $389/mo, struck through, as the list price for that same annual plan.
What you actually pay
Fridays' own single-item, no-promo, no-commitment product page charges $389 for a "1 month supply" of compounded tirzepatide — more than double the advertised $198/mo figure. Sermorelin has no such gap: its own product page states a plain $259 for a "1-Month Supply," with no promo tiers found.
The catch
The advertised $198/mo requires committing to an annual plan AND applying a discount code; buy the identical compounded tirzepatide without either, per Fridays' own product page, and the price is $389/mo.
Other costs to budget for
Fridays' own Terms & Conditions state "ALL FEES ARE NON-REFUNDABLE, including if you cancel mid-cycle, decide not to continue treatment, or do not achieve desired results," and require 72 hours' notice before the next billing date to avoid another charge.
Liberty is a Vite single-page-app telehealth storefront selling compounded semaglutide, tirzepatide, and sermorelin (plus NAD+ and metformin, not boarded here).
$219/mo
advertised
Medium confidence
What's advertised
Liberty's own homepage, FAQ ("Pricing varies by treatment. Semaglutide starts at $199/month, Tirzepatide at $299/month"), and product-comparison table (which keys "$299/mo" directly to `slug:"tirzepatide-injection"`) all advertise $299/month for compounded tirzepatide.
What you actually pay
The tirzepatide-injection product's own pricing data — the same data that drives its "Add to cart" button — charges a flat $219/month for every month of its 6-month structured program (2.5mg through the 10-15mg maintenance range), not $299. The $299/month figure instead belongs to a separate, lower-dose "Tirzepatide Microdosing" longevity product. The same mismatch applies to semaglutide: advertised at "$199/month" sitewide, while the semaglutide-injection product's own pricing data charges a flat $129/month for its 5-month program.
The catch
Liberty's own marketing surfaces (homepage, FAQ, comparison table) quote a different product's price on the page for the one you're actually buying. The comparison table explicitly maps "$299/mo" to the tirzepatide-injection product by its own internal slug — but that exact product's own purchasable pricing data charges $219/mo. Read the specific product page's own price before you buy; don't trust the comparison table or FAQ figure.
Other costs to budget for
Sermorelin does not have this problem: Liberty's own FAQ range ("$116–$149/month" for "NAD+ and Sermorelin") and the sermorelin-injection product's own pricing data (a flat $116/month, 1-Month Supply) agree.
A 3-Month Supply option for sermorelin is priced at $122 in Liberty's own product data — whether that is a per-month or total figure could not be determined with confidence from the compiled site data; the unambiguous figure is the 1-Month Supply's flat $116/month.
Liberty's own Returns & Refund Policy states cancellations must be made "at least 3 business days before your next scheduled shipment to avoid being charged," and that "refunds are not provided for subscription fees already paid" once a charge posts. Opened or partially used medication cannot be returned.
PlexusDx runs its own checkout/intake flow rather than functioning as a lead-gen or comparison page — its homepage states "independent clinicians review intake and write prescriptions" and medication ships from a "state-licensed compounding pharmacy," unnamed.
$249/mo+
advertised
High confidence
What's advertised
PlexusDx's homepage advertises "Tirzepatide: Starts at $249/mo" and "Sermorelin: Starts at $129/mo" — no dose-tier breakdown found; its deeper product pages returned HTTP 429 on every attempt.
What you actually pay
No published figure above the $249 (tirzepatide) or $129 (sermorelin) floors — PlexusDx's own product pages, where a dose-tier breakdown would live, were not accessible to us (HTTP 429 on every attempt), so the number past the floor is unverified either way.
A telehealth program built around a named compounding pharmacy: Precision Telemed's own product pages state medication is filled by "Rush Pharmacy, a licensed 503A compounding pharmacy," and describe the pharmacy as shipping nationwide with temperature-controlled cold-chain delivery.
$249.99/mo
advertised
Medium confidence
What's advertised
Precision Telemed's own pages advertise sermorelin at "$149.99 the first month, then $179.99/month" (a flat maintenance rate) and tirzepatide at "$199 the first month, then $249.99/month," with a $179.99/mo flat rate available at the lowest (2mg) tirzepatide starting dose only.
What you actually pay
$179.99/month for sermorelin — a genuinely flat, stated ongoing rate. For tirzepatide, $249.99/month at most maintenance doses; the lower $179.99/mo figure applies only at the lowest (2mg) starting dose.
The catch
The number on the sign-up screen ("$149.99" or "$199") is a first-month price, not the ongoing rate — budget for $179.99/mo (sermorelin) or $249.99/mo (tirzepatide) instead.
Welling PLLC, a Washington professional limited liability company (539 Broadway, Tacoma, WA 98402, per its own Terms of Service and Privacy Policy), is a cash-pay telehealth clinic selling compounded semaglutide and compounded tirzepatide, plus "coming soon" hormone, peptide, skin, and hair protocols.
$275/mo
advertised
High confidence
What's advertised
Welling's own Pricing, FAQ, and Clinic pages state a flat "$275/mo" for compounded tirzepatide ("Compounded tirzepatide (all doses)"), with the FAQ phrasing it as "Tirzepatide starts at $275/month." No promo code or annual prepay is needed to see this figure.
What you actually pay
$275/month is the actual day-one, no-discount rate — identical across the three separate pages checked. An optional "streak" discount (10% off at a 10-day streak of daily in-app food logging, 20% at 20 days, 30% at 30 days) can lower the recurring charge to as low as "$192/mo" per Welling's own pricing page, but resets to zero the instant a single day is missed and must be re-earned; a patient who does not log daily pays $275 every month.
Other costs to budget for
Welling's own Pricing page states the only additional charge is "a lab test ordered as part of your clinical assessment," billed at direct cost and disclosed before it is ordered — not bundled into the $275 default.
The 14-day refund window in Welling's own Terms of Service (5.6) "ends immediately upon the earliest of the following that applies to your plan: the placement of a medication order..." — which its own FAQ says can happen within 24 hours of intake, with shipping 1-2 business days after that, so refund eligibility can evaporate within a day or two of signing up, not 14.
Welling's own /protocols overview page states a different figure, a flat "$224/mo" for undifferentiated "GLP-1 therapy," inconsistent with the "$190 sema / $275 tirz" breakdown on its Pricing, FAQ, and Clinic pages.
EOS Health, LLC is a telehealth platform selling compounded tirzepatide and compounded semaglutide (weight loss), compounded sermorelin and glutathione (longevity/peptides), plus men's health, women's health, and skincare lines.
$299/mo
advertised
Medium confidence
What's advertised
EOS Health's own compounded-tirzepatide page advertises "$149 first month, then $299/month all-inclusive price, regardless of dose. Cancel anytime." Its Sermorelin page states a flat "$120.00/month" with no first-month split. Both apply automatically at checkout with no discount code required for the default Monthly plan.
What you actually pay
$299/month for compounded tirzepatide from the second month onward — EOS Health's own product page states this is an "all-inclusive price, regardless of dose," and formulation add-ons (+Glycine, +B12) did not change the displayed price when checked directly. $120/month for compounded sermorelin, with no first-month discount found for that product.
The catch
The tirzepatide page leads with "$149 first month" directly next to "then $299/month" — disclosed in the same breath rather than buried, but still a real ~2x jump from the sign-up price to the standing one. Separate 3-month and 12-month prepay tiers advertise larger dollar-amount savings that were not independently walked through checkout to confirm as a per-month rate.
Other costs to budget for
EOS Health's own Refunds, Returns & Subscription Policy states, "OTHER THAN CANCELLATION DUE TO MEDICAL DISQUALIFICATION, IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION," and requires 72 hours' notice before the next billing date to avoid another charge.
Rejuve Meds' own homepage product cards advertise "$265" per month, labeled "per month," for compounded Tirzepatide Injections (and "$165" per month for Semaglutide Injections).
What you actually pay
The onboarding intake's own live billing-plan data — the same data its "Add to cart" flow reads — shows the $265 figure is the 12-Month Plan for Tirzepatide Injections: a single $3,180 charge billed upfront ($3,180 ÷ 12 = $265), not a recurring monthly price. The actual no-commitment "Monthly Plan," billed once per month with no prepay, is $349. (Semaglutide Injections follow the identical pattern: "$165/mo" is a $1,980 one-time 12-month prepay; the real Monthly Plan is $249.)
The catch
The advertised "per month" figure on Rejuve Meds' own product cards is a 12-month prepay plan's amortized rate, not a recurring monthly charge — the exact 'prepay tier misread as monthly' pattern this site's own research discipline flags. Its own onboarding checkout is separately configured to default the plan selector to the cheapest (prepay) option and to hide the order's total price, which compounds the effect: a reader who accepts the default sees a low per-month number and never sees the $3,180 (or $1,980) figure being charged to their card.
Other costs to budget for
No membership or platform fee was found anywhere in the onboarding intake's own billing data — every charge ties to a named medication plan.
Its own Refund & Cancellation Policy lists "Prescription medication orders," "Processed subscription charges," and "Prescription products already ordered or dispensed" as non-refundable categories, and states plainly, "Once a patient submits the initial medical intake, the order is considered in process and becomes non-refundable." A full refund is available only for medical ineligibility (found during the initial consult) or a verifiable billing error.
Semaglutide Orals+ ("High Dose Compounded Oral Medication") follows the same shape: 1-Month Supply is $279/mo standing, while the homepage's "$195/mo" figure is its own 12-month prepay ($2,340 upfront) amortized.
"Tirzepatide Oral Tablets," marketed on the homepage at "$295/mo," is not one of the three offering codes the onboarding checkout's own configuration allows a reader to actually purchase.
Empower Pharmacy states, sitewide, in its own words, that it operates as both "a 503A compounding pharmacy and 503B outsourcing facility" that fills prescriptions — it does not run a telehealth program, write prescriptions, or offer a clinician visit of any kind.
Not published
no price published
Low confidence
What's advertised
Pricing not published anywhere on Empower's public site. Its own FAQ states plainly, "To determine a product's price, Empower Pharmacy requires a prescription since compounded medications differ from pharmacy to pharmacy" — a real figure exists only once an actual prescription is on file.
What you actually pay
Pricing not published. Because no month-to-month program exists — Empower fills individual prescriptions, not a subscription — there is no monthly figure to compare against any other row on either board, in either direction.
Other costs to budget for
Empower's own FAQ states it "does not accept insurance" at all, because compounded medications lack the NDC numbers insurers require to reimburse a claim — cash, FSA, or HSA only, per its own payment-methods answer.
No price was published anywhere on the provider's public site as of 2026-08-02.
“Advertised” is the number on the sign-up page. “What you actually pay” is what a reader who buys one month at a time really gets billed — a first-month teaser, a prepay tier, or a floor with no ceiling all show up as a gap between the two.
No price we didn't see
Every figure here was read directly off a provider's own site on the date shown. We don't estimate a $/mg rate from a dose we'd have to guess at — where a provider publishes nothing, the row says so and sorts last.
Nothing on this page is medical advice. Every product listed is compounded tirzepatide, made by a pharmacy under FDA compounding rules — not Zepbound, the FDA-approved brand. We read every price directly off each provider's own site on 2026-08-02; providers change prices without telling us, so verify the current number before you buy.
